Skip to main content
NCBI home page
Bulletin of the New York Academy of Medicine logoLink to Bulletin of the New York Academy of Medicine
. 1990 Mar-Apr;66(2):123–163.

Environmental teratogens.

R L Brent 1, D A Beckman 1
PMCID: PMC1809745  PMID: 2194610

Abstract

By far the largest category of malformations, 65% falls into the group of those with an unknown cause(s). Purely genetic causes of malformations (autosomal and cytogenetic), estimated to produce 20 to 25% of all human malformations, comprise the largest group of congenital malformations with known etiology. Although environmental causes of human malformations account for 10% or fewer of malformations, most of these environmentally induced malformations are related to maternal disease states. Fewer than 1% of all human malformations are related to drug exposure, chemicals, or radiation, but studies of environmentally induced malformations are important because they may teach us how to predict and test for teratogenicity, understand the mechanisms of teratogenesis from all etiologies, and provide a means by which human malformations can be prevented.

Full text

PDF
123

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Albengres E., Tillement J. P. Phenytoin in pregnancy: a review of the reported risks. Biol Res Pregnancy Perinatol. 1983;4(2):71–74. [PubMed] [Google Scholar]
  2. Alcohol has a lot to do with alcholism. Lancet. 1981 Feb 21;1(8217):425–426. [PubMed] [Google Scholar]
  3. Amin-Zaki L., Elhassani S., Majeed M. A., Clarkson T. W., Doherty R. A., Greenwood M. Intra-uterine methylmercury poisoning in Iraq. Pediatrics. 1974 Nov;54(5):587–595. [PubMed] [Google Scholar]
  4. Amin-Zaki L., Majeed M. A., Elhassani S. B., Clarkson T. W., Greenwood M. R., Doherty R. A. Prenatal methylmercury poisoning. Clinical observations over five years. Am J Dis Child. 1979 Feb;133(2):172–177. [PubMed] [Google Scholar]
  5. Anderson L. J., Hurwitz E. S. Human parvovirus B19 and pregnancy. Clin Perinatol. 1988 Jun;15(2):273–286. [PubMed] [Google Scholar]
  6. BEVELANDER G., COHLAN S. Q. The effect on the rat fetus of transplacentally acquired tetracycline. Biol Neonat. 1962;4:365–370. doi: 10.1159/000239846. [DOI] [PubMed] [Google Scholar]
  7. BRENT R. L. DRUG TESTING IN ANIMALS FOR TERATOGENIC EFFECTS. THALIDOMIDE IN THE PREGNANT RAT. J Pediatr. 1964 May;64:762–770. doi: 10.1016/s0022-3476(64)80626-0. [DOI] [PubMed] [Google Scholar]
  8. BURROW G. N. NEONATAL GOITER AFTER MATERNAL PROPYLTHIOURACIL THERAPY. J Clin Endocrinol Metab. 1965 Mar;25:403–408. doi: 10.1210/jcem-25-3-403. [DOI] [PubMed] [Google Scholar]
  9. Bai P. V., John T. J. Congenital skin ulcers following varicella in late pregnancy. J Pediatr. 1979 Jan;94(1):65–67. doi: 10.1016/s0022-3476(79)80354-6. [DOI] [PubMed] [Google Scholar]
  10. Barnes A. B., Colton T., Gundersen J., Noller K. L., Tilley B. C., Strama T., Townsend D. E., Hatab P., O'Brien P. C. Fertility and outcome of pregnancy in women exposed in utero to diethylstilbestrol. N Engl J Med. 1980 Mar 13;302(11):609–613. doi: 10.1056/NEJM198003133021105. [DOI] [PubMed] [Google Scholar]
  11. Barr M., Jr, Burdi A. R. Warfarin-associated embryopathy in a 17-week-old abortus. Teratology. 1976 Oct;14(2):129–134. doi: 10.1002/tera.1420140203. [DOI] [PubMed] [Google Scholar]
  12. Barr M., Jr, Poznanski A. K., Schmickel R. D. Digital hypoplasia and anticonvulsants during gestation: a teratogenic syndrome? J Pediatr. 1974 Feb;84(2):254–256. doi: 10.1016/s0022-3476(74)80615-3. [DOI] [PubMed] [Google Scholar]
  13. Beckman D. A., Brent R. L. Mechanism of known environmental teratogens: drugs and chemicals. Clin Perinatol. 1986 Sep;13(3):649–687. [PubMed] [Google Scholar]
  14. Berger M. J., Goldstein D. P. Impaired reproductive performance in DES-exposed women. Obstet Gynecol. 1980 Jan;55(1):25–27. [PubMed] [Google Scholar]
  15. Bernhardt I. B., Dorsey D. J. Hypervitaminosis A and congenital renal anomalies in a human infant. Obstet Gynecol. 1974 May;43(5):750–755. [PubMed] [Google Scholar]
  16. Blatt J., Mulvihill J. J., Ziegler J. L., Young R. C., Poplack D. G. Pregnancy outcome following cancer chemotherapy. Am J Med. 1980 Dec;69(6):828–832. doi: 10.1016/s0002-9343(80)80007-6. [DOI] [PubMed] [Google Scholar]
  17. Brent R. L. Bendectin and interventricular septal defects. Teratology. 1985 Oct;32(2):317–318. doi: 10.1002/tera.1420320219. [DOI] [PubMed] [Google Scholar]
  18. Brent R. L., Bolden B. T. The indirect effect of irradiation on embryonic development. 3. The contribution of ovarian irradiation, uterine irradiation, oviduct irradiation, and zygote irradiation to fetal mortality and growth retardation in the rat. Radiat Res. 1967 Apr;30(4):759–773. [PubMed] [Google Scholar]
  19. Brent R. L. Editorial comment on comments on "Teratogen update: Bendectin". Teratology. 1985 Jun;31(3):429–430. doi: 10.1002/tera.1420310314. [DOI] [PubMed] [Google Scholar]
  20. Brent R. L. Radiation teratogenesis. Teratology. 1980 Jun;21(3):281–298. doi: 10.1002/tera.1420210304. [DOI] [PubMed] [Google Scholar]
  21. Brown N. A., Shull G., Fabro S. Assessment of the teratogenic potential of trimethadione in the CD-1 mouse. Toxicol Appl Pharmacol. 1979 Oct;51(1):59–71. doi: 10.1016/0041-008x(79)90008-5. [DOI] [PubMed] [Google Scholar]
  22. Brown T., Anand A., Ritchie L. D., Clewley J. P., Reid T. M. Intrauterine parvovirus infection associated with hydrops fetalis. Lancet. 1984 Nov 3;2(8410):1033–1034. doi: 10.1016/s0140-6736(84)91126-7. [DOI] [PubMed] [Google Scholar]
  23. Burrow G. N., Klatskin E. H., Genel M. Intellectual development in children whose mothers received propylthiouracil during pregnancy. Yale J Biol Med. 1978 Mar-Apr;51(2):151–156. [PMC free article] [PubMed] [Google Scholar]
  24. Carswell F., Kerr M. M., Hutchison J. H. Congenital goitre and hypothyroidism produced by maternal ingestion of iodides. Lancet. 1970 Jun 13;1(7659):1241–1243. doi: 10.1016/s0140-6736(70)91736-8. [DOI] [PubMed] [Google Scholar]
  25. Carter C. O. Genetics of common single malformations. Br Med Bull. 1976 Jan;32(1):21–26. doi: 10.1093/oxfordjournals.bmb.a071318. [DOI] [PubMed] [Google Scholar]
  26. Caul E. O., Usher M. J., Burton P. A. Intrauterine infection with human parvovirus B19: a light and electron microscopy study. J Med Virol. 1988 Jan;24(1):55–66. doi: 10.1002/jmv.1890240108. [DOI] [PubMed] [Google Scholar]
  27. Chasnoff I. J., Burns W. J., Schnoll S. H., Burns K. A. Cocaine use in pregnancy. N Engl J Med. 1985 Sep 12;313(11):666–669. doi: 10.1056/NEJM198509123131105. [DOI] [PubMed] [Google Scholar]
  28. Chasnoff I. J., Chisum G. M., Kaplan W. E. Maternal cocaine use and genitourinary tract malformations. Teratology. 1988 Mar;37(3):201–204. doi: 10.1002/tera.1420370304. [DOI] [PubMed] [Google Scholar]
  29. Chasnoff I. J., Griffith D. R., MacGregor S., Dirkes K., Burns K. A. Temporal patterns of cocaine use in pregnancy. Perinatal outcome. JAMA. 1989 Mar 24;261(12):1741–1744. [PubMed] [Google Scholar]
  30. Chernoff G. F. The fetal alcohol syndrome in mice: maternal variables. Teratology. 1980 Aug;22(1):71–75. doi: 10.1002/tera.1420220110. [DOI] [PubMed] [Google Scholar]
  31. Cheron R. G., Kaplan M. M., Larsen P. R., Selenkow H. A., Crigler J. F., Jr Neonatal thyroid function after propylthiouracil therapy for maternal Graves' disease. N Engl J Med. 1981 Feb 26;304(9):525–528. doi: 10.1056/NEJM198102263040907. [DOI] [PubMed] [Google Scholar]
  32. Chávez G. F., Mulinare J., Cordero J. F. Maternal cocaine use during early pregnancy as a risk factor for congenital urogenital anomalies. JAMA. 1989 Aug 11;262(6):795–798. doi: 10.1001/jama.1989.03430060091031. [DOI] [PubMed] [Google Scholar]
  33. Coffee consumption during pregnancy. N Engl J Med. 1982 Jun 24;306(25):1548–1550. doi: 10.1056/NEJM198206243062510. [DOI] [PubMed] [Google Scholar]
  34. Congenital malformations. N Engl J Med. 1983 Aug 4;309(5):311–312. doi: 10.1056/NEJM198308043090514. [DOI] [PubMed] [Google Scholar]
  35. Constable J. D., Hatch M. C. Reproductive effects of herbicide exposure in Vietnam: recent studies by the Vietnamese and others. Teratog Carcinog Mutagen. 1985;5(4):231–250. doi: 10.1002/tcm.1770050404. [DOI] [PubMed] [Google Scholar]
  36. Corby D. G. Aspirin in pregnancy: maternal and fetal effects. Pediatrics. 1978 Nov;62(5 Pt 2 Suppl):930–937. [PubMed] [Google Scholar]
  37. Cossart Y. E., Field A. M., Cant B., Widdows D. Parvovirus-like particles in human sera. Lancet. 1975 Jan 11;1(7898):72–73. doi: 10.1016/s0140-6736(75)91074-0. [DOI] [PubMed] [Google Scholar]
  38. Dekaban A. S. Abnormalities in children exposed to x-radiation during various stages of gestation: tentative timetable of radiation injury to the human fetus. I. J Nucl Med. 1968 Sep;9(9):471–477. [PubMed] [Google Scholar]
  39. Dyban A. P., Sekirina G. G., Golinskii G. F. Deistvie aminopterina na kul'tiviruemye vne organizma doimplantatsionnye zarodyshi krys. Ontogenez. 1977;8(2):121–127. [PubMed] [Google Scholar]
  40. Döhler K. D., Hancke J. L., Srivastava S. S., Hofmann C., Shryne J. E., Gorski R. A. Participation of estrogens in female sexual differentiation of the brain; neuroanatomical, neuroendocrine and behavioral evidence. Prog Brain Res. 1984;61:99–117. doi: 10.1016/S0079-6123(08)64430-1. [DOI] [PubMed] [Google Scholar]
  41. Elshove J. Ceft palate in the offspring of female mice treated with phenytoin. Lancet. 1969 Nov 15;2(7629):1074–1074. doi: 10.1016/s0140-6736(69)90676-x. [DOI] [PubMed] [Google Scholar]
  42. Eriksson U. J., Dahlström E., Hellerström C. Diabetes in pregnancy. Skeletal malformations in the offspring of diabetic rats after intermittent withdrawal of insulin in early gestation. Diabetes. 1983 Dec;32(12):1141–1145. doi: 10.2337/diab.32.12.1141. [DOI] [PubMed] [Google Scholar]
  43. Eriksson U., Dahlström E., Larsson K. S., Hellerström C. Increased incidence of congenital malformations in the offspring of diabetic rats and their prevention by maternal insulin therapy. Diabetes. 1982 Jan;31(1):1–6. doi: 10.2337/diab.31.1.1. [DOI] [PubMed] [Google Scholar]
  44. FIUMARA N. J., FLEMING W. L., DOWNING J. G., GOOD F. L. The incidence of prenatal syphilis at the Boston City Hospital. N Engl J Med. 1952 Jul 10;247(2):48–52. doi: 10.1056/NEJM195207102470203. [DOI] [PubMed] [Google Scholar]
  45. Fantel A. G., Shepard T. H., Newell-Morris L. L., Moffett B. C. Teratogenic effects of retinoic acid in pigtail monkeys (Macaca nemestrina). I. General features. Teratology. 1977 Feb;15(1):65–71. doi: 10.1002/tera.1420150109. [DOI] [PubMed] [Google Scholar]
  46. Fedrick J. Epilepsy and pregnancy: a report from the Oxford Record Linkage Study. Br Med J. 1973 May 26;2(5864):442–448. doi: 10.1136/bmj.2.5864.442. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Feldman G. L., Weaver D. D., Lovrien E. W. The fetal trimethadione syndrome: report of an additional family and further delineation of this syndrome. Am J Dis Child. 1977 Dec;131(12):1389–1392. doi: 10.1001/archpedi.1977.02120250071012. [DOI] [PubMed] [Google Scholar]
  48. Ferencz C., Matanoski G. M., Wilson P. D., Rubin J. D., Neill C. A., Gutberlet R. Maternal hormone therapy and congenital heart disease. Teratology. 1980 Apr;21(2):225–239. doi: 10.1002/tera.1420210213. [DOI] [PubMed] [Google Scholar]
  49. Ferrer I., Xumetra A., Santamaría J. Cerebral malformation induced by prenatal X-irradiation: an autoradiographic and Golgi study. J Anat. 1984 Jan;138(Pt 1):81–93. [PMC free article] [PubMed] [Google Scholar]
  50. Finnell R. H. Phenytoin-induced teratogenesis: a mouse model. Science. 1981 Jan 30;211(4481):483–484. doi: 10.1126/science.7455686. [DOI] [PubMed] [Google Scholar]
  51. Florman A. L., Gershon A. A., Blackett P. R., Nahmias A. J. Intrauterine infection with herpes simplex virus. Resultant congenital malformations. JAMA. 1973 Jul 9;225(2):129–132. [PubMed] [Google Scholar]
  52. Fotherby K. A new look at progestogens. Clin Obstet Gynaecol. 1984 Dec;11(3):701–722. [PubMed] [Google Scholar]
  53. Frankenburg W. K., Duncan B. R., Coffelt R. W., Koch R., Coldwell J. G., Son C. D. Maternal phenylketonuria: implications for growth and development. J Pediatr. 1968 Oct;73(4):560–570. doi: 10.1016/s0022-3476(68)80271-9. [DOI] [PubMed] [Google Scholar]
  54. Fraser F. C. The multifactorial/threshold concept -- uses and misuses. Teratology. 1976 Dec;14(3):267–280. doi: 10.1002/tera.1420140302. [DOI] [PubMed] [Google Scholar]
  55. Friedman J. M. Does Agent Orange cause birth defects? Teratology. 1984 Apr;29(2):193–221. doi: 10.1002/tera.1420290208. [DOI] [PubMed] [Google Scholar]
  56. Fritz H., Hess R. Effects of cyclophosphamide on embryonic development in the rabbit. Agents Actions. 1971 Aug;2(2):83–86. doi: 10.1007/BF01990086. [DOI] [PubMed] [Google Scholar]
  57. GARCIA R. E., FRIEDMAN W. F., KABACK M. M., ROWE R. D. IDIOPATHIC HYPERCALCEMIA AND SUPRAVALVULAR AORTIC STENOSIS. DOCUMENTATION OF A NEW SYNDROME. N Engl J Med. 1964 Jul 16;271:117–120. doi: 10.1056/NEJM196407162710302. [DOI] [PubMed] [Google Scholar]
  58. GOETSCH C. An evaluation of aminopterin as an abortifacient. Am J Obstet Gynecol. 1962 Jun 1;83:1474–1477. doi: 10.1016/s0002-9378(16)35992-0. [DOI] [PubMed] [Google Scholar]
  59. GREENBERG L. H., TANAKA K. R. CONGENITAL ANOMALIES PROBABLY INDUCED BY CYCLOPHOSPHAMIDE. JAMA. 1964 May 4;188:423–426. doi: 10.1001/jama.1964.03060310023005. [DOI] [PubMed] [Google Scholar]
  60. GRUMBACH M. M., DUCHARME J. R., MOLOSHOK R. E. On the fetal masculinizing action of certain oral progestins. J Clin Endocrinol Metab. 1959 Nov;19:1369–1380. doi: 10.1210/jcem-19-11-1369. [DOI] [PubMed] [Google Scholar]
  61. Gal I., Kirman B., Stern J. Hormonal pregnancy tests and congenital malformation. Nature. 1967 Oct 7;216(5110):83–83. doi: 10.1038/216083a0. [DOI] [PubMed] [Google Scholar]
  62. Gal I. Risks and benefits of the use of hormonal pregnancy test tablets. Nature. 1972 Nov 24;240(5378):241–242. doi: 10.1038/240241a0. [DOI] [PubMed] [Google Scholar]
  63. Gaudier B., Ponté C., Duquennoy C., Callens G., Callens M., Ballester L. Retard de croissance intra-utérin avec microcéphalie chez trois enfants nés de mère hyperphénylalaninémique. Ann Pediatr (Paris) 1972 Apr;19(4):269–276. [PubMed] [Google Scholar]
  64. German J., Kowal A., Ehlers K. H. Trimethadione and human teratogenesis. Teratology. 1970 Nov;3(4):349–362. doi: 10.1002/tera.1420030412. [DOI] [PubMed] [Google Scholar]
  65. Gibson J. E., Becker B. A. The teratogenicity of cyclophosphamide in mice. Cancer Res. 1968 Mar;28(3):475–480. [PubMed] [Google Scholar]
  66. Gill W. B., Schumacher G. F., Bibbo M. Structural and functional abnormalities in the sex organs of male offspring of mothers treated with diethylstilbestrol (DES). J Reprod Med. 1976 Apr;16(4):147–153. [PubMed] [Google Scholar]
  67. Goldman A. S., Yaffe S. J. Fetal trimethadione syndrome. Teratology. 1978 Feb;17(1):103–105. doi: 10.1002/tera.1420170118. [DOI] [PubMed] [Google Scholar]
  68. Gordon B. H., Streeter M. L., Rosso P., Winick M. Prenatal alcohol exposure: abnormalities in placental growth and fetal amino acid uptake in the rat. Biol Neonate. 1985;47(2):113–119. doi: 10.1159/000242099. [DOI] [PubMed] [Google Scholar]
  69. Graham J. M., Miller M. E., Stephan M. J., Smith D. W. Limb reduction anomalies and early in utero limb compression. J Pediatr. 1980 Jun;96(6):1052–1056. doi: 10.1016/s0022-3476(80)80640-8. [DOI] [PubMed] [Google Scholar]
  70. Greener Y., Kochen J. A. In vitro studies on methyl mercury distribution in human blood. Teratology. 1983 Dec;28(3):375–387. doi: 10.1002/tera.1420280309. [DOI] [PubMed] [Google Scholar]
  71. Greenwald P., Barlow J. J., Nasca P. C., Burnett W. S. Vaginal cancer after maternal treatment with synthetic estrogens. N Engl J Med. 1971 Aug 12;285(7):390–392. doi: 10.1056/NEJM197108122850707. [DOI] [PubMed] [Google Scholar]
  72. Grossman J., 3rd Congenital syphilis. Teratology. 1977 Oct;16(2):217–219. doi: 10.1002/tera.1420160217. [DOI] [PubMed] [Google Scholar]
  73. HOFFMANN F., OVERZIER C., UHDE G. Zur Frage der hormonalen Erzeugung fötaler Zwitterbildungen beim Menschen. Geburtshilfe Frauenheilkd. 1955 Dec;15(12):1061–1070. [PubMed] [Google Scholar]
  74. HUGHES W. L. A physicochemical rationale for the biological activity of mercury and its compounds. Ann N Y Acad Sci. 1957 Apr 11;65(5):454–460. doi: 10.1111/j.1749-6632.1956.tb36650.x. [DOI] [PubMed] [Google Scholar]
  75. Hall J. G., Pauli R. M., Wilson K. M. Maternal and fetal sequelae of anticoagulation during pregnancy. Am J Med. 1980 Jan;68(1):122–140. doi: 10.1016/0002-9343(80)90181-3. [DOI] [PubMed] [Google Scholar]
  76. Hanify J. A., Metcalf P., Nobbs C. L., Worsley K. J. Aerial spraying of 2,4,5-T and human birth malformations: an epidemiological investigation. Science. 1981 Apr 17;212(4492):349–351. doi: 10.1126/science.7209535. [DOI] [PubMed] [Google Scholar]
  77. Hanson J. W., Myrianthopoulos N. C., Harvey M. A., Smith D. W. Risks to the offspring of women treated with hydantoin anticonvulsants, with emphasis on the fetal hydantoin syndrome. J Pediatr. 1976 Oct;89(4):662–668. doi: 10.1016/s0022-3476(76)80414-3. [DOI] [PubMed] [Google Scholar]
  78. Harada M. Congenital Minamata disease: intrauterine methylmercury poisoning. Teratology. 1978 Oct;18(2):285–288. doi: 10.1002/tera.1420180216. [DOI] [PubMed] [Google Scholar]
  79. Harbison R. D., Becker B. A. Relation of dosage and time of administration of diphenylhydantoin to its teratogenic effect in mice. Teratology. 1969 Nov;2(4):305–311. doi: 10.1002/tera.1420020405. [DOI] [PubMed] [Google Scholar]
  80. Heinonen O. P., Slone D., Monson R. R., Hook E. B., Shapiro S. Cardiovascular birth defects and antenatal exposure to female sex hormones. N Engl J Med. 1977 Jan 13;296(2):67–70. doi: 10.1056/NEJM197701132960202. [DOI] [PubMed] [Google Scholar]
  81. Herbst A. L., Kurman R. J., Scully R. E., Poskanzer D. C. Clear-cell adenocarcinoma of the genital tract in young females. Registry report. N Engl J Med. 1972 Dec 21;287(25):1259–1264. doi: 10.1056/NEJM197212212872501. [DOI] [PubMed] [Google Scholar]
  82. Herbst A. L., Poskanzer D. C., Robboy S. J., Friedlander L., Scully R. E. Prenatal exposure to stilbestrol. A prospective comparison of exposed female offspring with unexposed controls. N Engl J Med. 1975 Feb 13;292(7):334–339. doi: 10.1056/NEJM197502132920704. [DOI] [PubMed] [Google Scholar]
  83. Herbst A. L., Ulfelder H., Poskanzer D. C. Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. N Engl J Med. 1971 Apr 15;284(15):878–881. doi: 10.1056/NEJM197104222841604. [DOI] [PubMed] [Google Scholar]
  84. Hersh J. H., Podruch P. E., Rogers G., Weisskopf B. Toluene embryopathy. J Pediatr. 1985 Jun;106(6):922–927. doi: 10.1016/s0022-3476(85)80238-9. [DOI] [PubMed] [Google Scholar]
  85. Hill R. M., Verniaud W. M., Horning M. G., McCulley L. B., Morgan N. F. Infants exposed in utero to antiepileptic drugs. A prospective study. Am J Dis Child. 1974 May;127(5):645–653. doi: 10.1001/archpedi.1974.02110240031002. [DOI] [PubMed] [Google Scholar]
  86. Inouye M., Hoshino K., Murakami U. Effect of methylmercuric chloride on embryonic and fetal development in rats and mice. Annu Rep Res Inst Environ Med Nagoya Univ. 1972;19:69–74. [PubMed] [Google Scholar]
  87. Janerich D. T., Dugan J. M., Standfast S. J., Strite L. Congenital heart disease and prenatal exposure to exogenous sex hormones. Br Med J. 1977 Apr 23;1(6068):1058–1060. doi: 10.1136/bmj.1.6068.1058. [DOI] [PMC free article] [PubMed] [Google Scholar]
  88. Janerich D. T., Piper J. M., Glebatis D. M. Oral contraceptives and congenital limb-reduction defects. N Engl J Med. 1974 Oct 3;291(14):697–700. doi: 10.1056/NEJM197410032911403. [DOI] [PubMed] [Google Scholar]
  89. Johansen K. T. Lithium teratogenicity. Lancet. 1971 May 15;1(7707):1026–1027. doi: 10.1016/s0140-6736(71)91430-9. [DOI] [PubMed] [Google Scholar]
  90. Jones K. L., Smith D. W., Streissguth A. P., Myrianthopoulos N. C. Outcome in offspring of chronic alcoholic women. Lancet. 1974 Jun 1;1(7866):1076–1078. doi: 10.1016/s0140-6736(74)90555-8. [DOI] [PubMed] [Google Scholar]
  91. Jones K. L., Smith D. W. The fetal alcohol syndrome. Teratology. 1975 Aug;12(1):1–10. doi: 10.1002/tera.1420120102. [DOI] [PubMed] [Google Scholar]
  92. Kaplan L. C. Congenital Dandy Walker malformation associated with first trimester warfarin: a case report and literature review. Teratology. 1985 Dec;32(3):333–337. doi: 10.1002/tera.1420320302. [DOI] [PubMed] [Google Scholar]
  93. Katz Z., Lancet M., Skornik J., Chemke J., Mogilner B. M., Klinberg M. Teratogenicity of progestogens given during the first trimester of pregnancy. Obstet Gynecol. 1985 Jun;65(6):775–780. [PubMed] [Google Scholar]
  94. Kennedy L. A. The pathogenesis of brain abnormalities in the fetal alcohol syndrome: an integrating hypothesis. Teratology. 1984 Jun;29(3):363–368. doi: 10.1002/tera.1420290306. [DOI] [PubMed] [Google Scholar]
  95. Kerber I. J., Warr O. S., 3rd, Richardson C. Pregnancy in a patient with a prosthetic mitral valve. Associated with a fetal anomaly attributed to warfarin sodium. JAMA. 1968 Jan 15;203(3):223–225. [PubMed] [Google Scholar]
  96. Klein K. L., Scott W. J., Wilson J. G. Aspirin-induced teratogenesis: a unique pattern of cell death and subsequent polydactyly in the rat. J Exp Zool. 1981 Apr;216(1):107–112. doi: 10.1002/jez.1402160111. [DOI] [PubMed] [Google Scholar]
  97. Knott P. D., Welply G. A., Anderson M. J. Serologically proved intrauterine infection with parvovirus. Br Med J (Clin Res Ed) 1984 Dec 15;289(6459):1660–1660. doi: 10.1136/bmj.289.6459.1660. [DOI] [PMC free article] [PubMed] [Google Scholar]
  98. Korones S. B. Congenital rubella--an encapsulated review. Teratology. 1976 Aug;14(1):111–114. doi: 10.1002/tera.1420140113. [DOI] [PubMed] [Google Scholar]
  99. Kunita N., Hori S., Obana H., Otake T., Nishimura H., Kashimoto T., Ikegami N. Biological effect of PCBs, PCQs and PCDFs present in the oil causing yusho and yu-cheng. Environ Health Perspect. 1985 Feb;59:79–84. doi: 10.1289/ehp.59-1568087. [DOI] [PMC free article] [PubMed] [Google Scholar]
  100. Kuratsune M., Yoshimura T., Matsuzaka J., Yamaguchi A. Epidemiologic study on Yusho, a Poisoning Caused by Ingestion of Rice Oil Contaminated with a Commercial Brand of Polychlorinated Biphenyls. Environ Health Perspect. 1972 Apr;1:119–128. doi: 10.1289/ehp.7201119. [DOI] [PMC free article] [PubMed] [Google Scholar]
  101. LASH J. W. NORMAL EMBRYOLOGY AND TERATOGENESIS: IMPLICATIONS FOR PATHOLOGICAL DEVELOPMENT FROM EXPERIMENT EMBRYOLOGY. Am J Obstet Gynecol. 1964 Dec 1;90:SUPPL–SUPPL:1207. [PubMed] [Google Scholar]
  102. LENZ W., KNAPP K. Thalidomide embryopathy. Arch Environ Health. 1962 Aug;5:100–105. [PubMed] [Google Scholar]
  103. Lammer E. J., Flannery D. B., Barr M. Does isotretinoin cause limb reduction defects? Lancet. 1985 Aug 10;2(8450):328–328. doi: 10.1016/s0140-6736(85)90370-8. [DOI] [PubMed] [Google Scholar]
  104. Landesman-Dwyer S., Emanuel I. Smoking during pregnancy. Teratology. 1979 Feb;19(1):119–125. doi: 10.1002/tera.1420190116. [DOI] [PubMed] [Google Scholar]
  105. Larsen J. W., Jr Congenital toxoplasmosis. Teratology. 1977 Apr;15(2):213–217. doi: 10.1002/tera.1420150212. [DOI] [PubMed] [Google Scholar]
  106. Larsen J. W., Jr, Greendale K. ACOG Technical Bulletin Number 84--February 1985: teratology. Teratology. 1985 Dec;32(3):493–496. doi: 10.1002/tera.1420320319. [DOI] [PubMed] [Google Scholar]
  107. Larsson G., Bohlin A. B., Tunell R. Prospective study of children exposed to variable amounts of alcohol in utero. Arch Dis Child. 1985 Apr;60(4):316–321. doi: 10.1136/adc.60.4.316. [DOI] [PMC free article] [PubMed] [Google Scholar]
  108. Lash J. W., Saxén L. Human teratogenesis: invitro studies on thalidomide-inhibited chondrogenesis. Dev Biol. 1972 May;28(1):61–70. doi: 10.1016/0012-1606(72)90126-1. [DOI] [PubMed] [Google Scholar]
  109. Laurence K. M., James N., Miller M. H., Tennant G. B., Campbell H. Double-blind randomised controlled trial of folate treatment before conception to prevent recurrence of neural-tube defects. Br Med J (Clin Res Ed) 1981 May 9;282(6275):1509–1511. doi: 10.1136/bmj.282.6275.1509. [DOI] [PMC free article] [PubMed] [Google Scholar]
  110. Laurence M., Miller M., Vowles M., Evans K., Carter C. Hormonal pregnancy tests and neural tube malformations. Nature. 1971 Oct 15;233(5320):495–496. doi: 10.1038/233495b0. [DOI] [PubMed] [Google Scholar]
  111. Leary F. J., Resseguie L. J., Kurland L. T., O'Brien P. C., Emslander R. F., Noller K. L. Males exposed in utero to diethylstilbestrol. JAMA. 1984 Dec 7;252(21):2984–2989. [PubMed] [Google Scholar]
  112. Lenke R. R., Levy H. L. Maternal phenylketonuria and hyperphenylalaninemia. An international survey of the outcome of untreated and treated pregnancies. N Engl J Med. 1980 Nov 20;303(21):1202–1208. doi: 10.1056/NEJM198011203032104. [DOI] [PubMed] [Google Scholar]
  113. Lewis W. H., Suris O. R. Treatment with lithium carbonate. Results in 35 cases. Tex Med. 1970 Dec;66(12):58–63. [PubMed] [Google Scholar]
  114. Liss A., Hakkarainen K., Jansson E. Acholeplasma laidlawii retains sensitivity to exogenous virus while releasing endogenous, mitomycin C induced, virus. Brief report. Arch Virol. 1985;85(1-2):165–170. doi: 10.1007/BF01317017. [DOI] [PubMed] [Google Scholar]
  115. London W. T., Levitt N. H., Kent S. G., Wong V. G., Sever J. L. Congenital cerebral and ocular malformations induced in rhesus monkeys by Venezuelan equine encephalitis virus. Teratology. 1977 Dec;16(3):285–285. doi: 10.1002/tera.1420160307. [DOI] [PubMed] [Google Scholar]
  116. MARTIN M. M., RENTO R. D. Iodide goiter with hypothyroidism in 2 newborn infants. J Pediatr. 1962 Jul;61:94–99. doi: 10.1016/s0022-3476(62)80235-2. [DOI] [PubMed] [Google Scholar]
  117. MELTZER H. J. Congenital anomalies due to attempted abortion with 4-aminopteroglutamic acid. J Am Med Assoc. 1956 Jul 28;161(13):1253–1253. doi: 10.1001/jama.1956.62970130002010a. [DOI] [PubMed] [Google Scholar]
  118. Marchant B., Brownlie B. E., Hart D. M., Horton P. W., Alexander W. D. The placental transfer of propylthiouracil, methimazole and carbimazole. J Clin Endocrinol Metab. 1977 Dec;45(6):1187–1193. doi: 10.1210/jcem-45-6-1187. [DOI] [PubMed] [Google Scholar]
  119. Matsumoto H., Koya G., Takeuchi T. Fetal Minamata disease. A neuropathological study of two cases of intrauterine intoxication by a methyl mercury compound. J Neuropathol Exp Neurol. 1965 Oct;24(4):563–574. [PubMed] [Google Scholar]
  120. Mauvais-Jarvis P., Crepy Q., Bercovici J. P. Further studies on the pathophysiology of testicular feminization syndrome. J Clin Endocrinol Metab. 1971 Apr;32(4):568–571. doi: 10.1210/jcem-32-4-568. [DOI] [PubMed] [Google Scholar]
  121. Maydl R., Metzler M. Oxidative metabolites of diethylstilbestrol in the fetal Syrian golden hamster. Teratology. 1984 Dec;30(3):351–357. doi: 10.1002/tera.1420300307. [DOI] [PubMed] [Google Scholar]
  122. McBride W. G. Fetal nerve cell degeneration produced by thalidomide in rabbits. Teratology. 1974 Dec;10(3):283–291. doi: 10.1002/tera.1420100311. [DOI] [PubMed] [Google Scholar]
  123. McBride W. G. Studies of the etiology of thalidomide dysmorphogenesis. Teratology. 1976 Aug;14(1):71–87. doi: 10.1002/tera.1420140110. [DOI] [PubMed] [Google Scholar]
  124. McBride W. G. Thalidomide embryopathy. Teratology. 1977 Aug;16(1):79–82. doi: 10.1002/tera.1420160113. [DOI] [PubMed] [Google Scholar]
  125. McCarroll A. M., Hutchinson M., McAuley R., Montogomery D. A. Long-term assessment of children exposed in utero to carbimazole. Arch Dis Child. 1976 Jul;51(7):532–536. doi: 10.1136/adc.51.7.532. [DOI] [PMC free article] [PubMed] [Google Scholar]
  126. McClain R. M., Langhoff L. Teratogenicity of diphenylhydantoin in the New Zealand white rabbit. Teratology. 1980 Jun;21(3):371–379. doi: 10.1002/tera.1420210315. [DOI] [PubMed] [Google Scholar]
  127. McCredie J., McBride W. G. Some congenital abnormalities: possibly due to embryonic peripheral neuropathy. Clin Radiol. 1973 Apr;24(2):204–211. doi: 10.1016/s0009-9260(73)80083-2. [DOI] [PubMed] [Google Scholar]
  128. McCredie J. Sclerotome subtraction: a radiologic interpretation of reduction deformities of the limbs. Birth Defects Orig Artic Ser. 1977;13(3D):65–77. [PubMed] [Google Scholar]
  129. McLachlan J. A. Prenatal exposure to diethylstilbestrol in mice: toxicological studies. J Toxicol Environ Health. 1977 Jan;2(3):527–537. doi: 10.1080/15287397709529453. [DOI] [PubMed] [Google Scholar]
  130. Mcclure H. M., Wilk A. L., Horigan E. A., Pratt R. M. Induction of craniofacial malformations in rhesus monkeys (Macaca mulatta) with cyclophosphamide. Cleft Palate J. 1979 Jul;16(3):248–256. [PubMed] [Google Scholar]
  131. Miller E., Cradock-Watson J. E., Pollock T. M. Consequences of confirmed maternal rubella at successive stages of pregnancy. Lancet. 1982 Oct 9;2(8302):781–784. doi: 10.1016/s0140-6736(82)92677-0. [DOI] [PubMed] [Google Scholar]
  132. Miller R. K., Heckmann M. E., McKenzie R. C. Diethylstilbestrol: placental transfer, metabolism, covalent binding and fetal distribution in the Wistar rat. J Pharmacol Exp Ther. 1982 Feb;220(2):358–365. [PubMed] [Google Scholar]
  133. Miller R. W. Congenital PCB poisoning: a reevaluation. Environ Health Perspect. 1985 May;60:211–214. doi: 10.1289/ehp.8560211. [DOI] [PMC free article] [PubMed] [Google Scholar]
  134. Miller R. W. Delayed radiation effects in atomic-bomb survivors. Major observations by the Atomic Bomb Casualty Commission are evaluated. Science. 1969 Oct 31;166(3905):569–574. doi: 10.1126/science.166.3905.569. [DOI] [PubMed] [Google Scholar]
  135. Miller R. W., Mulvihill J. J. Small head size after atomic irradiation. Teratology. 1976 Dec;14(3):355–357. doi: 10.1002/tera.1420140311. [DOI] [PubMed] [Google Scholar]
  136. Mills J. L. Malformations in infants of diabetic mothers. Teratology. 1982 Jun;25(3):385–394. doi: 10.1002/tera.1420250316. [DOI] [PubMed] [Google Scholar]
  137. Milunsky A., Graef J. W., Gaynor M. F., Jr Methotrexate-induced congenital malformations. J Pediatr. 1968 Jun;72(6):790–795. doi: 10.1016/s0022-3476(68)80430-5. [DOI] [PubMed] [Google Scholar]
  138. Mirkes P. E. Cyclophosphamide teratogenesis: a review. Teratog Carcinog Mutagen. 1985;5(2):75–88. doi: 10.1002/tcm.1770050202. [DOI] [PubMed] [Google Scholar]
  139. Monson R. R., Rosenberg L., Hartz S. C., Shapiro S., Heinonen O. P., Slone D. Diphenylhydantoin and selected congenital malformations. N Engl J Med. 1973 Nov 15;289(20):1049–1052. doi: 10.1056/NEJM197311152892001. [DOI] [PubMed] [Google Scholar]
  140. Mottet N. K. Effects of chronic low-dose exposure of rat fetuses to methylmercury hydroxide. Teratology. 1974 Oct;10(2):173–189. doi: 10.1002/tera.1420100214. [DOI] [PubMed] [Google Scholar]
  141. Mounoud R. L., Klein D., Weber F. A propos d'un das de syndrome de Goldenhar: intox;cation aiguë à la vitamine A chez la mère pendant la grossesse. J Genet Hum. 1975 Jun;23(2):135–154. [PubMed] [Google Scholar]
  142. Mujtaba Q., Burrow G. N. Treatment of hyperthyroidism in pregnancy with propylthiouracil and methimazole. Obstet Gynecol. 1975 Sep;46(3):282–286. [PubMed] [Google Scholar]
  143. Naeye R. L., Blanc W. Pathogenesis of congenital rubella. JAMA. 1965 Dec 20;194(12):1277–1283. [PubMed] [Google Scholar]
  144. Naeye R. L. Effects of maternal cigarette smoking on the fetus and placenta. Br J Obstet Gynaecol. 1978 Oct;85(10):732–737. doi: 10.1111/j.1471-0528.1978.tb15593.x. [DOI] [PubMed] [Google Scholar]
  145. Nelson M. M., Forfar J. O. Associations between drugs administered during pregnancy and congenital abnormalities of the fetus. Br Med J. 1971 Mar 6;1(5748):523–527. doi: 10.1136/bmj.1.5748.523. [DOI] [PMC free article] [PubMed] [Google Scholar]
  146. Newbold R. R., Bullock B. C., Mc Lachlan J. A. Exposure to diethylstilbestrol during pregnancy permanently alters the ovary and oviduct. Biol Reprod. 1983 Apr;28(3):735–744. doi: 10.1095/biolreprod28.3.735. [DOI] [PubMed] [Google Scholar]
  147. Nieburg P., Marks J. S., McLaren N. M., Remington P. L. The fetal tobacco syndrome. JAMA. 1985 May 24;253(20):2998–2999. [PubMed] [Google Scholar]
  148. O'Brien P. C., Noller K. L., Robboy S. J., Barnes A. B., Kaufman R. H., Tilley B. C., Townsend D. E. Vaginal epithelial changes in young women enrolled in the National Cooperative Diethylstilbestrol Adenosis (DESAD) project. Obstet Gynecol. 1979 Mar;53(3):300–308. [PubMed] [Google Scholar]
  149. O'Malley B. W., Schrader W. T. The receptors of steroid hormones. Sci Am. 1976 Feb;234(2):32–43. doi: 10.1038/scientificamerican0276-32. [DOI] [PubMed] [Google Scholar]
  150. Oser B. L., Ford R. A. Caffeine: an update. Drug Chem Toxicol. 1981;4(4):311–329. doi: 10.3109/01480548109017824. [DOI] [PubMed] [Google Scholar]
  151. PEDERSEN J. Weight and length at birth of infants of diabetic mothers. Acta Endocrinol (Copenh) 1954 Aug;16(4):330–342. doi: 10.1530/acta.0.0160330. [DOI] [PubMed] [Google Scholar]
  152. Pearn J. H. Teratogens and the male. An analysis with special reference to herbicide exposure. Med J Aust. 1983 Jul 9;2(1):16–20. doi: 10.5694/j.1326-5377.1983.tb142079.x. [DOI] [PubMed] [Google Scholar]
  153. Pettifor J. M., Benson R. Congenital malformations associated with the administration of oral anticoagulants during pregnancy. J Pediatr. 1975 Mar;86(3):459–462. doi: 10.1016/s0022-3476(75)80986-3. [DOI] [PubMed] [Google Scholar]
  154. Powell H. R., Ekert H. Methotrexate-induced congenital malformations. Med J Aust. 1971 Nov 20;2(21):1076–1077. doi: 10.5694/j.1326-5377.1971.tb92712.x. [DOI] [PubMed] [Google Scholar]
  155. Prager K., Malin H., Spiegler D., Van Natta P., Placek P. J. Smoking and drinking behavior before and during pregnancy of married mothers of live-born infants and stillborn infants. Public Health Rep. 1984 Mar-Apr;99(2):117–127. [PMC free article] [PubMed] [Google Scholar]
  156. RUSSELL L. B., RUSSELL W. L. An analysis of the changing radiation response of the developing mouse embryo. J Cell Physiol Suppl. 1954 May;43(Suppl 1):103–149. doi: 10.1002/jcp.1030430407. [DOI] [PubMed] [Google Scholar]
  157. Rantakallio P. The effect of maternal smoking on birth weight and the subsequent health of the child. Early Hum Dev. 1978 Dec;2(4):371–382. doi: 10.1016/0378-3782(78)90064-6. [DOI] [PubMed] [Google Scholar]
  158. Reggiani G. Medical problems raised by the TCDD contamination in Seveso, Italy. Arch Toxicol. 1978 Jun 16;40(3):161–188. doi: 10.1007/BF00364649. [DOI] [PubMed] [Google Scholar]
  159. Reynolds D. W., Stagno S., Alford C. A. Congenital cytomegalovirus infection. Teratology. 1978 Apr;17(2):179–181. doi: 10.1002/tera.1420170211. [DOI] [PubMed] [Google Scholar]
  160. Rock J. A., Wentz A. C., Cole K. A., Kimball A. W., Jr, Zacur H. A., Early S. A., Jones G. S. Fetal malformations following progesterone therapy during pregnancy: a preliminary report. Fertil Steril. 1985 Jul;44(1):17–19. doi: 10.1016/s0015-0282(16)48670-x. [DOI] [PubMed] [Google Scholar]
  161. Rodesch F., Camus M., Ermans A. M., Dodion J., Delange F. Adverse effect of amniofetography on fetal thyroid function. Am J Obstet Gynecol. 1976 Nov 15;126(6):723–726. doi: 10.1016/0002-9378(76)90528-7. [DOI] [PubMed] [Google Scholar]
  162. Rogan W. J. PCBs and cola-colored babies: Japan, 1968, and Taiwan, 1979. Teratology. 1982 Dec;26(3):259–261. doi: 10.1002/tera.1420260307. [DOI] [PubMed] [Google Scholar]
  163. Rosenberg L., Mitchell A. A., Shapiro S., Slone D. Selected birth defects in relation to caffeine-containing beverages. JAMA. 1982 Mar 12;247(10):1429–1432. [PubMed] [Google Scholar]
  164. SPEERT H., QUIMBY E. H., WERNER S. C. Radioiodine uptake by the fetal mouse thyroid and resultant effects in later life. Surg Gynecol Obstet. 1951 Aug;93(2):230–242. [PubMed] [Google Scholar]
  165. Sadler T. W. Effects of maternal diabetes on early embryogenesis: I. The teratogenic potential of diabetic serum. Teratology. 1980 Jun;21(3):339–347. doi: 10.1002/tera.1420210310. [DOI] [PubMed] [Google Scholar]
  166. Sadler T. W. Effects of maternal diabetes on early embryogenesis: II. Hyperglycemia-induced exencephaly. Teratology. 1980 Jun;21(3):349–356. doi: 10.1002/tera.1420210311. [DOI] [PubMed] [Google Scholar]
  167. Safra M. J., Oakley G. P., Jr Association between cleft lip with or without cleft palate and prenatal exposure to diazepam. Lancet. 1975 Sep 13;2(7933):478–480. doi: 10.1016/s0140-6736(75)90548-6. [DOI] [PubMed] [Google Scholar]
  168. Saxén I. Associations between oral clefts and drugs taken during pregnancy. Int J Epidemiol. 1975 Mar;4(1):37–44. doi: 10.1093/ije/4.1.37. [DOI] [PubMed] [Google Scholar]
  169. Schenkel B., Vorherr H. Non-prescription drugs during pregnancy: potential teratogenic and toxic effects upon embryo and fetus. J Reprod Med. 1974 Jan;12(1):27–45. [PubMed] [Google Scholar]
  170. Seegmiller R. E., Nelson G. W., Johnson C. K. Evaluation of the teratogenic potential of delalutin (17 alpha-hydroxyprogesterone caproate) in mice. Teratology. 1983 Oct;28(2):201–208. doi: 10.1002/tera.1420280208. [DOI] [PubMed] [Google Scholar]
  171. Selevan S. G., Lindbohm M. L., Hornung R. W., Hemminki K. A study of occupational exposure to antineoplastic drugs and fetal loss in nurses. N Engl J Med. 1985 Nov 7;313(19):1173–1178. doi: 10.1056/NEJM198511073131901. [DOI] [PubMed] [Google Scholar]
  172. Sever J. L. Infections in pregnancy: highlights from the collaborative perinatal project. Teratology. 1982 Apr;25(2):227–237. doi: 10.1002/tera.1420250212. [DOI] [PubMed] [Google Scholar]
  173. Sever L. E. Hormonal pregnancy tests and spina bifida. Nature. 1973 Apr 6;242(5397):410–411. doi: 10.1038/242410a0. [DOI] [PubMed] [Google Scholar]
  174. Shapiro S., Hartz S. C., Siskind V., Mitchell A. A., Slone D., Rosenberg L., Monson R. R., Heinonen O. P. Anticonvulsants and parental epilepsy in the development of birth defects. Lancet. 1976 Feb 7;1(7954):272–275. doi: 10.1016/s0140-6736(76)91403-3. [DOI] [PubMed] [Google Scholar]
  175. Shiota K. Embryotoxic effects of polychlorinated biphenyls (Kanechlors 300 and 500) in rats. Okajimas Folia Anat Jpn. 1976 Aug;53(2-3):93–104. doi: 10.2535/ofaj1936.53.2-3_93. [DOI] [PubMed] [Google Scholar]
  176. Shiota K. Postnatal behavioral effects of prenatal treatment with PCBs (polychlorinated biphenyls) in rats. Okajimas Folia Anat Jpn. 1976 Aug;53(2-3):105–114. doi: 10.2535/ofaj1936.53.2-3_105. [DOI] [PubMed] [Google Scholar]
  177. Singh S. The teratogenicity of cyclophosphamide (endoxan-asta) in rats. Indian J Med Res. 1971 Jul;59(7):1128–1135. [PubMed] [Google Scholar]
  178. Skalko R. G., Gold M. P. Teratogenicity of methotrexate in mice. Teratology. 1974 Apr;9(2):159–163. doi: 10.1002/tera.1420090206. [DOI] [PubMed] [Google Scholar]
  179. Slone D., Siskind V., Heinonen O. P., Monson R. R., Kaufman D. W., Shapiro S. Aspirin and congenital malformations. Lancet. 1976 Jun 26;1(7974):1373–1375. doi: 10.1016/s0140-6736(76)93025-7. [DOI] [PubMed] [Google Scholar]
  180. Snyder R. D. Congenital mercury poisoning. N Engl J Med. 1971 May 6;284(18):1014–1016. doi: 10.1056/NEJM197105062841806. [DOI] [PubMed] [Google Scholar]
  181. South M. A., Sever J. L. Teratogen update: the congenital rubella syndrome. Teratology. 1985 Apr;31(2):297–307. doi: 10.1002/tera.1420310216. [DOI] [PubMed] [Google Scholar]
  182. South M. A., Tompkins W. A., Morris C. R., Rawls W. E. Congenital malformation of the central nervous system associated with genital type (type 2) herpesvirus. J Pediatr. 1969 Jul;75(1):13–18. doi: 10.1016/s0022-3476(69)80096-x. [DOI] [PubMed] [Google Scholar]
  183. Speidel B. D., Meadow S. R. Maternal epilepsy and abnormalities of the fetus and newborn. Lancet. 1972 Oct 21;2(7782):839–843. doi: 10.1016/s0140-6736(72)92209-x. [DOI] [PubMed] [Google Scholar]
  184. Spyker J. M., Smithberg M. Effects of methylmercury on prenatal development in mice. Teratology. 1972 Apr;5(2):181–190. doi: 10.1002/tera.1420050208. [DOI] [PubMed] [Google Scholar]
  185. Stenflo J., Suttie J. W. Vitamin K-dependent formation of gamma-carboxyglutamic acid. Annu Rev Biochem. 1977;46:157–172. doi: 10.1146/annurev.bi.46.070177.001105. [DOI] [PubMed] [Google Scholar]
  186. Stephens T. D., McNulty T. R. Evidence for a metameric pattern in the development of the chick humerus. J Embryol Exp Morphol. 1981 Feb;61:191–205. [PubMed] [Google Scholar]
  187. Stoffer S. S., Hamburger J. I. Inadvertent 131I therapy for hyperthyroidism in the first trimester of pregnancy. J Nucl Med. 1976 Feb;17(02):146–149. [PubMed] [Google Scholar]
  188. Stokes P. A., Lykke W. J., McBride W. G. Ultrastructural changes in the dorsal root ganglia evoked by thalidomide in rabbits. Experientia. 1976 May 15;32(5):597–599. doi: 10.1007/BF01990184. [DOI] [PubMed] [Google Scholar]
  189. Strecker T. R., Stephens T. D. Peripheral nerves do not play a trophic role in limb skeletal morphogenesis. Teratology. 1983 Apr;27(2):159–167. doi: 10.1002/tera.1420270204. [DOI] [PubMed] [Google Scholar]
  190. Streissguth A. P., Landesman-Dwyer S., Martin J. C., Smith D. W. Teratogenic effects of alcohol in humans and laboratory animals. Science. 1980 Jul 18;209(4454):353–361. doi: 10.1126/science.6992275. [DOI] [PubMed] [Google Scholar]
  191. Szabo K. T. Teratogenic effect of lithium carbonate in the foetal mouse. Nature. 1970 Jan 3;225(5227):73–75. doi: 10.1038/225073a0. [DOI] [PubMed] [Google Scholar]
  192. THIERSCH J. B. Therapeutic abortions with a folic acid antagonist, 4-aminopteroylglutamic acid (4-amino P.G.A) administered by the oral route. Am J Obstet Gynecol. 1952 Jun;63(6):1298–1304. doi: 10.1016/s0002-9378(16)38924-4. [DOI] [PubMed] [Google Scholar]
  193. Tanaka H., Nakazawa K., Arima M. Adverse effect of maternal caffeine ingestion on fetal cerebrum in rat. Brain Dev. 1983;5(4):397–406. doi: 10.1016/s0387-7604(83)80045-x. [DOI] [PubMed] [Google Scholar]
  194. Toledo T. M., Harper R. C., Moser R. H. Fetal effects during cyclophosphamide and irradiation therapy. Ann Intern Med. 1971 Jan;74(1):87–91. doi: 10.7326/0003-4819-74-1-87. [DOI] [PubMed] [Google Scholar]
  195. Ulfelder H. DES-transplacental teratogen-and possibly also carcinogen. Teratology. 1976 Feb;13(1):101–103. doi: 10.1002/tera.1420130115. [DOI] [PubMed] [Google Scholar]
  196. Vacaflor L., Lehmann H. E., Ban T. A. Side effects and teratogenicity of lithium carbonate treatment. J Clin Pharmacol J New Drugs. 1970 Nov-Dec;10(6):387–389. [PubMed] [Google Scholar]
  197. VanBlerk G. A., Majerus T. C., Myers R. A. Teratogenic potential of some psychopharmacologic drugs: a brief review. Int J Gynaecol Obstet. 1980 Jan-Feb;17(4):399–402. doi: 10.1002/j.1879-3479.1980.tb00312.x. [DOI] [PubMed] [Google Scholar]
  198. Veridiano N. P., Delke I., Rogers J., Tancer M. L. Reproductive performance of DES-exposed female progeny. Obstet Gynecol. 1981 Jul;58(1):58–61. [PubMed] [Google Scholar]
  199. Vorherr H., Messer R. H., Vorherr U. F., Jordan S. W., Kornfeld M. Teratogenesis and carcinogenesis in rat offspring after transplacental and transmammary exposure to diethylstilbestrol. Biochem Pharmacol. 1979 Jun 15;28(12):1865–1877. doi: 10.1016/0006-2952(79)90638-5. [DOI] [PubMed] [Google Scholar]
  200. WARKANY J., BEAUDRY P. H., HORNSTEIN S. Attempted abortion with aminopterin (4-amino-pteroylglutamic acid); malformations of the child. AMA J Dis Child. 1959 Mar;97(3):274–281. doi: 10.1001/archpedi.1959.02070010276003. [DOI] [PubMed] [Google Scholar]
  201. WILKINS L., JONES H. W., Jr, HOLMAN G. H., STEMPFEL R. S., Jr Masculinization of the female fetus associated with administration of oral and intramuscular progestins during gestation: non-adrenal female pseudohermaphrodism. J Clin Endocrinol Metab. 1958 Jun;18(6):559–585. doi: 10.1210/jcem-18-6-559. [DOI] [PubMed] [Google Scholar]
  202. WILKINS L. Masculinization of female fetus due to use of orally given progestins. J Am Med Assoc. 1960 Mar 5;172:1028–1032. doi: 10.1001/jama.1960.03020100036007. [DOI] [PubMed] [Google Scholar]
  203. Warkany J. A warfarin embryopathy? Am J Dis Child. 1975 Mar;129(3):287–288. doi: 10.1001/archpedi.1975.02120400005001. [DOI] [PubMed] [Google Scholar]
  204. Warkany J. Aminopterin and methotrexate: folic acid deficiency. Teratology. 1978 Jun;17(3):353–357. doi: 10.1002/tera.1420170314. [DOI] [PubMed] [Google Scholar]
  205. Warkany J. Teratogen update: iodine deficiency. Teratology. 1985 Apr;31(2):309–311. doi: 10.1002/tera.1420310217. [DOI] [PubMed] [Google Scholar]
  206. Warkany J. Warfarin embryopathy. Teratology. 1976 Oct;14(2):205–209. doi: 10.1002/tera.1420140211. [DOI] [PubMed] [Google Scholar]
  207. Weisblum B., Davies J. Antibiotic inhibitors of the bacterial ribosome. Bacteriol Rev. 1968 Dec;32(4 Pt 2):493–528. [PMC free article] [PubMed] [Google Scholar]
  208. Wenger F. Venezuelan equine encephalitis. Teratology. 1977 Dec;16(3):359–362. doi: 10.1002/tera.1420160317. [DOI] [PubMed] [Google Scholar]
  209. Werler M. M., Pober B. R., Holmes L. B. Smoking and pregnancy. Teratology. 1985 Dec;32(3):473–481. doi: 10.1002/tera.1420320316. [DOI] [PubMed] [Google Scholar]
  210. Wilson C. B., Remington J. S., Stagno S., Reynolds D. W. Development of adverse sequelae in children born with subclinical congenital Toxoplasma infection. Pediatrics. 1980 Nov;66(5):767–774. [PubMed] [Google Scholar]
  211. Wilson J. G., Brent R. L. Are female sex hormones teratogenic? Am J Obstet Gynecol. 1981 Nov 1;141(5):567–580. doi: 10.1016/s0002-9378(15)33279-8. [DOI] [PubMed] [Google Scholar]
  212. Wilson J. G. Mechanisms of teratogenesis. Am J Anat. 1973 Feb;136(2):129–131. doi: 10.1002/aja.1001360202. [DOI] [PubMed] [Google Scholar]
  213. Wilson J. G., Scott W. J., Ritter E. J., Fradkin R. Comparative distribution and embryotoxicity of methotrexate in pregnant rats and rhesus monkeys. Teratology. 1979 Feb;19(1):71–79. doi: 10.1002/tera.1420190111. [DOI] [PubMed] [Google Scholar]
  214. Wiseman R. A., Dodds-Smith I. C. Cardiovascular birth defects and antenatal exposure to female sex hormones: a reevaluation of some base data. Teratology. 1984 Dec;30(3):359–370. doi: 10.1002/tera.1420300308. [DOI] [PubMed] [Google Scholar]
  215. Wolff M. S. Occupational exposure to polychlorinated biphenyls (PCBs). Environ Health Perspect. 1985 May;60:133–138. doi: 10.1289/ehp.8560133. [DOI] [PMC free article] [PubMed] [Google Scholar]
  216. Wood J. W., Johnson K. G., Omori Y. In utero exposure to the Hiroshima atomic bomb. An evaluation of head size and mental retardation: twenty years later. Pediatrics. 1967 Mar;39(3):385–392. [PubMed] [Google Scholar]
  217. Wood J. W., Johnson K. G., Omori Y., Kawamoto S., Keehn R. J. Mental retardation in children exposed in utero to the atomic bombs in Hiroshima and Nagasaki. Am J Public Health Nations Health. 1967 Aug;57(8):1381–1389. doi: 10.2105/ajph.57.8.1381. [DOI] [PMC free article] [PubMed] [Google Scholar]
  218. Yang M. G., Krawford K. S., Garcia J. D., Wang J. H., Lei K. Y. Deposition of mercury in fetal and maternal brain. Proc Soc Exp Biol Med. 1972 Dec;141(3):1004–1007. doi: 10.3181/00379727-141-36920. [DOI] [PubMed] [Google Scholar]
  219. Zackai E. H., Mellman W. J., Neiderer B., Hanson J. W. The fetal trimethadione syndrome. J Pediatr. 1975 Aug;87(2):280–284. doi: 10.1016/s0022-3476(75)80603-2. [DOI] [PubMed] [Google Scholar]
  220. Zierler S., Rothman K. J. Congenital heart disease in relation to maternal use of Bendectin and other drugs in early pregnancy. N Engl J Med. 1985 Aug 8;313(6):347–352. doi: 10.1056/NEJM198508083130603. [DOI] [PubMed] [Google Scholar]

Articles from Bulletin of the New York Academy of Medicine are provided here courtesy of New York Academy of Medicine

RESOURCES